Accuray (ARAY) Down 32% Since Last Earnings Report: Can It Rebound?

07.03.25 17:30 Uhr

Werte in diesem Artikel
Aktien

1,36 EUR -0,14 EUR -9,33%

It has been about a month since the last earnings report for Accuray (ARAY). Shares have lost about 32% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Accuray due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Accuray Q2 Earnings & Revenues Beat Estimates, Margins UpAccuray Incorporated reported second-quarter fiscal 2025 earnings per share of 2 cents against the year-ago period’s loss of 10 cents. The bottom line surpassed the Zacks Consensus Estimate by 300%.Revenues in DetailAccuray registered quarterly revenues of $116.2 million, up 8.3% year over year. The figure beat the Zacks Consensus Estimate by 4.7%.The overall top-line growth was driven by robust growth in product revenue and solid demand for its CyberKnife system.Segmental DetailsAccuray derives revenues from two sources — Products and Services.In the fiscal second quarter, Product revenues increased 18.7% from the year-ago quarter’s level to $61.2 million.Services revenues declined 1.3% year over year to $54.9 million.Gross product orders totaled $76.8 million, down 18.2% year over year. The book-to-bill ratio was 1.3 in the fiscal second quarter compared with 1.8 in the year-ago quarter.Margin TrendIn the quarter under review, Accuray’s gross profit improved 16.7% year over year to $41.9 million. Gross margin expanded 260 basis points to 36.1%.Selling and marketing expenses decreased 2.2% year over year to $11.1 million. Research and development expenses decreased 10.7% year over year to $13.6 million. General and administrative expenses also went down 6% year over year to $12.4 million. Total operating expenses of $37.2 million decreased 6.7% year over year.Operating profit totaled $4.7 million against the prior-year quarter’s operating loss of $3.9 million.Financial PositionAccuray exited the second quarter of fiscal 2025 with cash and cash equivalents of $62.6 million compared with $59.7 million at the end of the first quarter of fiscal 2025.Total debt (including short-term debt) at the fiscal second-quarter end was $175.5 million compared with $170.2 million at the end of the first quarter of fiscal 2025.GuidanceAccuray has raised its revenue outlook for fiscal 2025 based on current expectations.The company now expects revenues in the range of $463-$475 million (reflecting year-over-year growth of 3.5-5.7%) compared with the previous guidance of $462-$472 million. The Zacks Consensus Estimate is pegged at $468.6 million.How Have Estimates Been Moving Since Then?It turns out, estimates review have trended downward during the past month.Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Accuray Incorporated (ARAY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Accuray und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Accuray

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Accuray

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Accuray IncShs

Wer­bung

Analysen zu Accuray IncShs

DatumRatingAnalyst
30.11.2017Accuray BuyLake Street
22.12.2015Accuray Sector PerformRBC Capital Markets
01.05.2015Accuray BuyDougherty & Company LLC
12.01.2015Accuray OutperformNorthland Capital
06.11.2007Accuray günstig bewertetGlobal Biotech Investing
DatumRatingAnalyst
30.11.2017Accuray BuyLake Street
01.05.2015Accuray BuyDougherty & Company LLC
12.01.2015Accuray OutperformNorthland Capital
06.11.2007Accuray günstig bewertetGlobal Biotech Investing
DatumRatingAnalyst
22.12.2015Accuray Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Accuray IncShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen